Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029770 · ClinicalTrials.gov registry record · Phase 2
Chiropractic Care, Medication, and Self-Care for Neck Pain
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 270
- Enrollment target
NCT00029770: Completed Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00029770 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 270 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (103% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029770, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 270 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of chiropractic care, medications, and self-care on neck pain, a very common condition. The broad, long-term objective of this study is to identify effective therapies for neck pain sufferers and to increase understanding of neck pain conditions.
Interventions
- DRUG Acetaminophen
- PROCEDURE Chiropractic spinal manipulation
- BEHAVIORAL Self-care
- DRUG Non-Steroidal anti-inflammatory drugs (NSAIDS)
- DRUG Tylenol with codeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2001-09 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
What the finished NCT00029770 record still lists
NCT00029770 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (103% higher).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT00029770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029770 about?
NCT00029770 is a clinical study titled "Chiropractic Care, Medication, and Self-Care for Neck Pain". This study will compare the effectiveness of chiropractic care, medications, and self-care on neck pain, a very common condition. The broad, long-term objective of this study is to identify effective therapies for neck pain sufferers and to increase understanding of neck pain conditions.
What is the current status of trial NCT00029770?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 270 participants. The study started on 2001-09. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00029770?
The interventions under investigation include: Acetaminophen (DRUG), Chiropractic spinal manipulation (PROCEDURE), Self-care (BEHAVIORAL), Non-Steroidal anti-inflammatory drugs (NSAIDS) (DRUG), Tylenol with codeine (DRUG).
Who is sponsoring clinical trial NCT00029770?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00029770's enrollment target sits among peer trials
270 205th of 2000 higher than 1,793 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia